Subtopic Deep Dive

Prenylated Flavonoids Enzyme Inhibition
Research Guide

What is Prenylated Flavonoids Enzyme Inhibition?

Prenylated flavonoids enzyme inhibition studies the inhibitory effects of prenylated flavonoids on enzymes such as tyrosinase, aldose reductase, and xanthine oxidase derived from plants like Sophora flavescens and Artocarpus species.

Researchers isolate prenylated flavonoids from Sophora flavescens and Artocarpus altilis to evaluate their inhibition of tyrosinase for melanin reduction (Hyun et al., 2008, 106 citations) and aldose reductase for diabetic complications (Jung et al., 2008, 86 citations). Over 10 key papers document structure-activity relationships and therapeutic potentials, with the most cited review by Shamsudin et al. (2022, 161 citations) covering antidiabetic and anti-inflammatory effects. These compounds show promise in pigmentation disorders and inflammation.

Curated Papers

Key Challenges

Why It Matters

Prenylated flavonoids inhibit tyrosinase, reducing melanin synthesis for skin-whitening applications (Hyun et al., 2008; Kim et al., 2003). They block aldose reductase and AGE formation, targeting diabetic complications (Jung et al., 2008). Sophora flavescens extracts demonstrate antitumor enzyme modulation via COX inhibition (Sun et al., 2012), supporting treatments for hyperuricemia, pain, and cancer with low toxicity.

Key Research Challenges

Structure-Activity Optimization

Prenylated flavonoids vary in inhibitory potency based on prenyl position and substitution, requiring precise SAR analysis (Shamsudin et al., 2022). Isolating active isomers from complex plant matrices remains labor-intensive (Lan et al., 2013). Standardization across species like Sophora flavescens hinders reproducibility (Hyun et al., 2008).

Enzyme Selectivity Profiling

Compounds like kurarinol inhibit tyrosinase but need testing against off-target enzymes like COX (Sun et al., 2012). Balancing potency across tyrosinase, aldose reductase, and xanthine oxidase is challenging (Jung et al., 2008). In vivo validation lags behind in vitro data (Kim et al., 2003).

Bioavailability Enhancement

Prenylated flavonoids exhibit poor solubility, limiting therapeutic delivery despite strong enzyme inhibition (Shamsudin et al., 2022). Metabolic stability in humans requires further pharmacokinetic studies. Clinical translation from plant extracts to formulations faces scalability issues (Lan et al., 2013).

Essential Papers

Flavonoids as Antidiabetic and Anti-Inflammatory Agents: A Review on Structural Activity Relationship-Based Studies and Meta-Analysis

Nur Farisya Shamsudin, Qamar Uddin Ahmed, Syed Mahmood et al. · 2022 · International Journal of Molecular Sciences · 161 citations

Flavonoids are a group of naturally occurring polyphenolic secondary metabolites which have been reported to demonstrate a wide range of pharmacological properties, most importantly, antidiabetic a...

Inhibitory Effects of Kurarinol, Kuraridinol, and Trifolirhizin from Sophora flavescens on Tyrosinase and Melanin Synthesis

Sook Kyung Hyun, Won‐Hee Lee, Da Mi Jeong et al. · 2008 · Biological and Pharmaceutical Bulletin · 106 citations

Previously, it was reported that some prenylated flavonoids contained in the dichloromethane fraction of the ethanolic extract of Sophora flavescens, such as kuraridin, sophoraflavanone G, kurarino...

Antitumor Activities of Kushen: Literature Review

Mingyu Sun, Hongyan Cao, Lin Sun et al. · 2012 · Evidence-based Complementary and Alternative Medicine · 101 citations

To discover and develop novel natural compounds with therapeutic selectivity or that can preferentially kill cancer cells without significant toxicity to normal cells is an important area in cancer...

Prenylated flavonoids from Artocarpus altilis: Antioxidant activities and inhibitory effects on melanin production

Wen-Chun Lan, Cheng-Wei Tzeng, Chun‐Ching Lin et al. · 2013 · Phytochemistry · 97 citations

Antimicrobial activities of the methanol extract and compounds from Artocarpus communis (Moraceae)

Victor Kuete, Patrick Y. Ango, Ghislain W. Fotso et al. · 2011 · BMC Complementary and Alternative Medicine · 97 citations

Inhibitory activities of prenylated flavonoids from <i>Sophora flavescens</i> against aldose reductase and generation of advanced glycation endproducts

Hyun Ah Jung, Na Young Yoon, Sam Sik Kang et al. · 2008 · Journal of Pharmacy and Pharmacology · 86 citations

Abstract Important targets for the prevention and treatment of diabetic complications include aldose reductase (AR) inhibitors (ARIs) and inhibitors of advanced glycation endproduct (AGE) formation...

Tyrosinase Inhibitory Prenylated Flavonoids from Sophora flavescens

Soo Jin Kim, Kun Ho Son, Hyun Wook Chang et al. · 2003 · Biological and Pharmaceutical Bulletin · 83 citations

For the purpose of the development of a skin-whitening agent, Sophora flavescens was evaluated for tyrosinase inhibitory activity and its active principles were identified following activity-guided...

Reading Guide

Foundational Papers

Start with Hyun et al. (2008, 106 citations) for tyrosinase inhibition by kurarinol from Sophora flavescens, then Jung et al. (2008, 86 citations) for aldose reductase data, and Lan et al. (2013, 97 citations) for Artocarpus melanin effects to build core mechanisms.

Recent Advances

Study Shamsudin et al. (2022, 161 citations) for SAR meta-analysis on antidiabetic/anti-inflammatory roles; Batiha et al. (2023, 80 citations) reviews Morus alba flavonoids extending prenylation insights.

Core Methods

Activity-guided fractionation, tyrosinase/melanin assays (Hyun et al., 2008), aldose reductase IC50 measurement (Jung et al., 2008), and antioxidant/melanin production screens (Lan et al., 2013).

How PapersFlow Helps You Research Prenylated Flavonoids Enzyme Inhibition

Discover & Search

Research Agent uses searchPapers('prenylated flavonoids tyrosinase inhibition Sophora flavescens') to retrieve Hyun et al. (2008, 106 citations), then citationGraph to map 50+ related works from Sophora and Artocarpus, and findSimilarPapers to uncover Lan et al. (2013) on melanin inhibition.

Analyze & Verify

Analysis Agent applies readPaperContent on Hyun et al. (2008) to extract IC50 values for kurarinol, verifies inhibition claims with verifyResponse (CoVe) against Jung et al. (2008), and runs PythonAnalysis to plot SAR dose-response curves using NumPy/pandas, graded by GRADE for evidence strength.

Synthesize & Write

Synthesis Agent detects gaps in aldose reductase selectivity via gap detection across Shamsudin et al. (2022) and Jung et al. (2008), flags contradictions in antitumor claims (Sun et al., 2012); Writing Agent uses latexEditText for SAR tables, latexSyncCitations, latexCompile for reports, and exportMermaid for enzyme inhibition pathway diagrams.

Use Cases

"Compare IC50 values of prenylated flavonoids from Sophora flavescens on tyrosinase across papers"

Research Agent → searchPapers → Analysis Agent → readPaperContent (Hyun 2008, Kim 2003) → runPythonAnalysis (pandas table of IC50s, matplotlib plot) → GRADE verification → exportCsv of normalized inhibition data.

"Draft a review section on Artocarpus prenylated flavonoids for tyrosinase inhibition"

Synthesis Agent → gap detection (Lan 2013) → Writing Agent → latexEditText (intro paragraph) → latexSyncCitations (add Kuete 2011) → latexCompile (PDF section) → exportBibtex.

"Find computational models or code for prenylated flavonoid docking simulations"

Research Agent → searchPapers('prenylated flavonoids enzyme docking') → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis (re-run docking script with new flavonoids).

Automated Workflows

Deep Research workflow conducts systematic review: searchPapers (50+ Sophora/Artocarpus papers) → citationGraph → DeepScan (7-step IC50 extraction/verification) → structured report on enzyme targets. Theorizer generates hypotheses on prenyl group effects from Hyun (2008) + Jung (2008) data chains. DeepScan verifies SAR claims across Shamsudin (2022) with CoVe checkpoints.

Try Doxa for Prenylated Flavonoids Enzyme Inhibition Research

Frequently Asked Questions

What defines prenylated flavonoids enzyme inhibition?

It examines how prenylated flavonoids from Sophora flavescens and Artocarpus inhibit tyrosinase, aldose reductase, and related enzymes, focusing on SAR for therapeutic use (Hyun et al., 2008; Jung et al., 2008).

What are key methods used?

Activity-guided isolation from plant extracts, in vitro enzyme assays for IC50, and melanin synthesis tests in cell models (Hyun et al., 2008; Lan et al., 2013).

What are the most cited papers?

Shamsudin et al. (2022, 161 citations) reviews antidiabetic effects; Hyun et al. (2008, 106 citations) details kurarinol tyrosinase inhibition; Jung et al. (2008, 86 citations) covers aldose reductase.

What open problems exist?

Improving bioavailability, achieving enzyme selectivity, and scaling in vivo studies beyond tyrosinase/aldose reductase (Shamsudin et al., 2022; Sun et al., 2012).